Skip to content

Two Different Doses of Tranexamic Acid for reduction of Perioperative Blood Loss in Cesarean Section: a randomized controlled study

Two Different Doses of Tranexamic Acid for reduction of Perioperative Blood Loss in Cesarean Section: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202208859856197
Enrollment
134
Registered
2022-08-10
Start date
2022-08-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

control group
study group

Sponsors

faculty of medicine suez canal university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Age from 18- 45 years. 2) Patients are ASA I (American Society of Anesthesiology physical status Grade I) = (normal healthy patients) or ASA II (American Society of Anesthesiologists physical status Grade II) = (patients with mild systemic disease and no functional limitations). 3) term with singleton uncomplicated pregnancies. 4) Body mass index of at most 40 kg/m2.

Exclusion criteria

Exclusion criteria: 1) Parturient with peri-partum disorders as DM, HTN, cardiac diseases, Sickle cell disease or bleeding disorders History of venous (deep vein thrombosis and/or pulmonary embolism) or arterial (angina pectoris, myocardial infarction, stroke) thrombosis. 2) Known case of coagulation disorders. 3) Severe anemia. 4) Allergy to TXA. 5) Severe medical and surgical complications involving the heart, liver, kidney, brain, and blood disorder. 6) Abnormal placenta such as placenta previa and placental abruption. 7) Pregnancy related complication like severe preeclampsia, 8) Pregnancy with <37 weeks gestational age. 9) Woman on anticoagulant therapy during the week 10) Refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
1.Amount pf perioperative blood loss as mentioned before 2.Change in hemoglobin level in gm measured after 48 hrs

Secondary

MeasureTime frame
3. Need for vasopressors to maintain blood pressure within accepted level 4. Incidence of severe PPH, defined by blood loss =1000 mL. 5. Incidence of nausea, vomiting and thrombosis

Countries

Egypt

Contacts

Public Contactomima taha

assistant professor suez canal university

omimatharwat@yahoo.com01223423685

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026